Büyük renal kitle: Olgu sunumu

Year 2011, Volume: 6 Issue: 3, 48 - 51, 01.08.2011

Cem Başataç Uğur Boylu Eyüp Gümüş

Abstract

Böbrek kanseri sık görülen ve ölüm oranları yüksek olan önemli ürolojik tümörlerden biridir. Erişkin tümörlerin yaklaşık % 3’ünü oluşturur. Böbreğin renal hücreli karsinomlardan RHK sonra en sık izlenen 2. primer malignansisi üroepitelyal kökenli tümörlerdir. Bu grupta en sık izlenen tümör değişici epitel hücreli karsinomdur. Renal pelvis değişici epitel hücreli kanserleri, tüm ürotelyal tümörlerin yaklaşık % 5’ini oluşturmaktadır. En sık yakınma makroskopik hematüridir ve olguların sadece %10-15’i asemptomatiktir.Bu yazıda görüntüleme yöntemleri ile boyutları 40 cm ye ulaşan retroperitoneal kistik kitleye sahip olan 52 yaşında erkek hasta sunuldu. Olgumuz güncel literatür ışığında tartışıldı

Keywords

Değişici epitelyum hücreli karsinom , uzak yayılım , retroperitoneal kitle

Huge renal mass: Case report

Abstract

Kidney cancer, which is common and has high mortality rates, is one of the most important urological tumors. Kidney cancer is approximately %3 of all adult tumors. The second most common tumor of the kidney after renal cell carcinomas is tumor of uroepithelium. Mostly observed tumor in this group is transitional cell carcinoma TCC . TCC of renal pelvis is about 5% of all urothelial tumors. The most common complaint is on macroscopic hematuria and only 10 to 15% of patients have no symptoms. In this article 52 year old male patient, who had a retroperitoneal cystic mass reaching up to 40 cm in size according to imaging techniques, was presented. Our case was discussed with the light of current literature

Keywords

Transitional cell carcinoma , wide spread , mass of retroperitoneum

References

• Gatewood OMB, Goldman SM, Marshall FF et all: Com- puterized tomography in the diagnosis of transitional cell carsinoma of the kidney. J Urol 1982;127:876-887
• Ressequie LT, Nobrega FT, Farrow GM et all: Epidemio- logy of renal and ureteral cancer in Rochester, Minnesota, 1950-1974, with special reference to clinical and patholo- gic features. Mayo Clin Proc 1978; 53:503
• Raabe NK, Fossa SD, Bjerkehagen B et all: Carcinoma of the renal pelvis. Scand J Urol Nephrol 1992; 26:357
• Guinan P, Vogelzang NJ, Randazzo R, et al: Renal pelvic cancer: A review of 611 patients treated in Illinois 1975- 1985. Urology 1992; 40:393
• Murphy DM, Zincke H, Furlow WL et all: Management of high grade transitional cell cancer of the upper urinary tract. J Urol 1981; 135:25
• Melamed MR, Reuter VE et all: Pathology and staging of urothelial tumors of the kidney and ureter. Urol Clin North Am 1993; 20:333.
• Jemal et al., 2004. Jemal A, Tiwari RC, Murray T, et all: Cancer statistics, 2004. CA Cancer J Clin 2004; 54:8
• Anderstrom C, Johansson SL, Pettersson S, et all: Carcino- ma of the ureter: A clinicopathologic study of 49 cases. J Urol 1989; 142:280
• Greenlee RT, Murray T, Bolden S et all: Cancer statistics, 2000. CA Cancer J Clin 2000; 50:7
• Sagalowsky AI, Jarrett TW et all: Management of urotheli- al tumors of the renal pelvis and ureter. In: Walsh PC, Re- tik AD, Vaughan ED, et al ed. Campbell’s Urology, Phila- delphia: WB Saunders; 2002:2845
• Shalhav AL, Dunn MD, Portis AJ et all: Laparoscopic neph- roureterectomy for upper tract transitional cell cancer: The Washington University experience. J Urol 2000; 163:1100
• Gill IS, Soble JJ, Miller SD et all: A novel technique for management of the en bloc bladder cuff and distal ure- ter during laparoscopic nephroureterectomy. J Urol 1999;161:430-434
• Thompson RH, Leibovich BC et all: Mangement of upper tract tumors. In Vogelzang NJ, Scardino PT, Shipley WU, Debruyne FMJ, Linehan WM (eds). Genitourinary Onco- logy 3 th edition. Philadelphia, Lippincott, Williams and Wilkins. 2005:435-432
• Jarrett TW, Sweetser PM, Weiss GH, Smith AD: Per- cutaneous management of transitional cell carcino- ma of the renal collecting system: 9-year experience. J Urol 1995;154:1629-1635
• Keeley FX, Bibbo M, Bagley DM: Ureteroscopic tre- atment and evaluation of the upper tract TCC. J Urol 1997; 157:1560-1565
• Patel A, Soonawalla P, Shepherd SF, et al: Long-term outco- me after percutaneous treatment of transitional cell carci- noma of the renal pelvis. J Urol 1996;155:868-874
• See WA: Continuous antegrade infusion of adriamycin as adjuvant therapy for upper tract urothelial malignanci- es. Urology 2000;56:216-222
• Kaufman D, Raghavan D, Carducci M et al: Phase II trial of gemcitabine plus cisplatin in patients with metastatic urot- helial cancer. J Clin Oncol. 2000 May;18(9):1921-27
• Von der Maase H, Sengelov L, Roberts JT et al: Long-term survival results of a randomized trial comparing gemcita- bine plus cisplatin, with methotrexate, vinblastine, doxo- rubicin, plus cisplatin in patients with bladder cancer. J Clin Oncol. 2005 Jul 20;23(21):4602-4608